Back to Search

SOPHIA KARY, PH.D.

PH.D.

Clinical Psychologist

NPI: 1770612194Individual

Specialties, Licenses & Credentials

Clinical PsychologistPrimary

Psychologist — Clinical

Code: 103TC0700X

PY 8259(MA)68 016000(NY)35SI 00440000(NJ)

Research & Publications (15)

New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.
PMID 16150791·Ann Rheum Dis·2006
5-case
Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis.
PMID 12723729·Int J Clin Pract·2003
6-review
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis.
PMID 19273449·J Rheumatol·2009
3-trial
Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion.
PMID 19254918·Rheumatology (Oxford)·2009
3-trial
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.
PMID 18662932·Ann Rheum Dis·2009
3-trial
An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status.
PMID 18350329·Clin Rheumatol·2008
3-trial
Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study.
PMID 18163417·Arthritis Rheum·2008
4-observational
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice.
PMID 17504821·Rheumatology (Oxford)·2007
3-trial
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.
PMID 17329305·Ann Rheum Dis·2007
3-trial
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.
PMID 17300238·Br J Dermatol·2007
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
1 NEVILLE STREET
CENTER MORICHES, NY 11934

Quick Facts

NPI
1770612194
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
3
Locations
1
Publications
15

Are you this provider?

Claim Your Profile